Mechanisms of renal disease in indigenous populations: influences at work in Canadian indigenous peoples

被引:32
作者
Dyck, RF [1 ]
机构
[1] Univ Saskatchewan, Coll Med, Dept Med, Div Nephrol, Saskatoon, SK S7N 0W0, Canada
关键词
aboriginal; Canada; diabetes; end-stage renal disease; glomerulonephritis;
D O I
10.1046/j.1440-1797.2001.00029.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Canadian aboriginal people experience end-stage renal disease at rates 2.5-4 times higher than those found in the general population. Up to 60% of cases are due to diabetic end-stage renal disease, while most of the remainder are caused by a variety of types of glomerulonephritis. The greatest increase in cases of end-stage renal disease among aboriginal people since 1981 has been observed in those with diabetes. There appear to be three major contributing influences to the increase in diabetic end-stage renal disease among Canadian aboriginal people. First, the rates of type 2 diabetes mellitus have increased from virtually zero to several times those seen in the general population in less than 60 years. Second, aboriginal people with diabetes have seven times the rate of diabetic end-stage renal disease compared with their non-aboriginal counterparts. Finally, birth rates among aboriginal people are higher than in any other segment of the population. An epidemic of diabetic end-stage renal disease is the most important nephrological issue facing Canadian aboriginal people and threatens to overwhelm health care resources in many parts of the country unless effective early recognition and prevention programmes are established.
引用
收藏
页码:3 / 7
页数:5
相关论文
共 11 条
[1]  
Chase LA, 1937, CAN MED ASSOC J, V36, P366
[2]  
DYCK RF, 1994, CAN MED ASSOC J, V150, P203
[3]  
Dyck RF, 1998, CLIN INVEST MED, V21, P33
[4]  
DYCK RF, 1995, CHRONIC DIS CAN, V16, P107
[5]  
Dyck RF, 1995, CHRONIC DIS CAN, V16, P24
[6]   The hepatic nuclear factor-1α G319S variant is associated with early-onset type 2 diabetes in Canadian Oji-Cree [J].
Hegele, RA ;
Cao, HI ;
Harris, SB ;
Hanley, AJG ;
Zinman, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (03) :1077-1082
[7]  
KLOMP H, THESIS U SASKATCHEWA
[8]  
NEEL JV, 1962, AM J HUM GENET, V14, P353
[9]   CONGENITAL SUSCEPTIBILITY TO NIDDM - ROLE OF INTRAUTERINE ENVIRONMENT [J].
PETTITT, DJ ;
ALECK, KA ;
BAIRD, HR ;
CARRAHER, MJ ;
BENNETT, PH ;
KNOWLER, WC .
DIABETES, 1988, 37 (05) :622-628
[10]  
Pioro MP, 1996, CAN J PUBLIC HEALTH, V87, P325